RO4 Comparison of Health Technology Assessments and Time to Reimbursement for Orphan Drugs from FOUR HTA Agencies: Opportunities and Challenges in France, Germany, England and Scotland
2020
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI